Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes. by King, B F et al.
Coexpression of Rat P2X2 and P2X6 Subunits in Xenopus Oocytes
B. F. King, A. Townsend-Nicholson, S. S. Wildman, T. Thomas, K. M. Spyer, and G. Burnstock
Autonomic Neuroscience Institute, Royal Free and University College Medical School, Royal Free Campus, Hampstead,
London NW3 2PF, United Kingdom
Transcripts for P2X2 and P2X6 subunits are present in rat CNS
and frequently colocalize in the same brainstem nuclei. When
rat P2X2 (rP2X2) and rat P2X6 (rP2X6) receptors were expressed
individually in Xenopus oocytes and studied under voltage-
clamp conditions, only homomeric rP2X2 receptors were fully
functional and gave rise to large inward currents (2–3 mA) to
extracellular ATP. Coexpression of rP2X2 and rP2X6 subunits in
Xenopus oocytes resulted in a heteromeric rP2X2/6 receptor,
which showed a significantly different phenotype from the wild-
type rP2X2 receptor. Differences included reduction in agonist
potencies and, in some cases (e.g., Ap4A), significant loss of
agonist activity. ATP-evoked inward currents were biphasic at
the heteromeric rP2X2/6 receptor, particularly when Zn
21 ions
were present or extracellular pH was lowered. The pH range
was narrower for H1 enhancement of ATP responses at the
heteromeric rP2X2/6 receptor. Also, H
1 ions inhibited ATP re-
sponses at low pH levels (,pH 6.3). The pH-dependent block-
ing activity of suramin was changed at this heteromeric recep-
tor, although the potentiating effect of Zn21 on ATP responses
was unchanged. Thus, the rP2X2/6 receptor is a functionally
modified P2X2-like receptor with a distinct pattern of pH mod-
ulation of ATP activation and suramin blockade. Although ho-
momeric P2X6 receptors function poorly, the P2X6 subunit can
contribute to functional heteromeric P2X channels and may
influence the phenotype of native P2X receptors in those cells
in which it is expressed.
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P2X receptors are ligand-gated cation channels that when acti-
vated by extracellular ATP mediate fast excitation in various cells,
including central and peripheral neurons (Burnstock, 1997). Neu-
ronal P2X receptors show considerable differences in their sensi-
tivity to naturally occurring agonists, P2 receptor antagonists,
and allosteric modulators and, furthermore, show differences in
kinetics of receptor activation and inactivation (Khakh et al.,
1995; King, 1998). Such diversity in the operational profiles of
ATP-gated ion channels may be attributable to the subunit com-
position of native P2X receptors, because other classes of iono-
tropic receptors show differing phenotypes that depend on sub-
unit composition (Barnard et al., 1998). Seven P2X receptor
subunits (P2X1–7) have been cloned, each of which is believed to
form functional homomeric assemblies (Buell et al., 1996). They
can also coassemble with other P2X subunits to form heteromeric
P2X receptors of three, or possibly four, protein subunits per
ATP-gated ion channel (Kim et al., 1997; Nicke et al., 1998;
Torres et al., 1999). Three functional heteromeric P2X receptors
have been reported: P2X2/3 (Lewis et al., 1995; Radford et al.,
1997), P2X4/6 (Leˆ et al., 1998), and P2X1/5 (Torres et al., 1998;
Haines et al., 1999; Leˆ et al., 1999). Heteromeric channels com-
posed of splice variants of the same P2X subunit (e.g., mP2X4 and
mP2X4a) can also generate a different phenotypic form of the
wild-type P2X receptor (Townsend-Nicholson et al., 1999).
The potential for heteropolymerization among P2X1–7 recep-
tor subunits was recently investigated using coimmunoprecipita-
tion procedures (Torres et al., 1999). For P2X subunits concen-
trated in the CNS (namely P2X2, P2X4, and P2X6) (Collo et al.,
1996), epitope-tagged P2X2 and P2X6 subunits or P2X4 and P2X6
subunits (but not P2X2 and P2X4 subunits) were shown to form
immunopositive heteromeric assemblies. The functional proper-
ties of heteromeric P2X4/6 receptors have been established (Leˆ et
al., 1998), but not yet the phenotype of heteromeric P2X2/6
receptors. The result of P2X2 and P2X6 subunit coexpression is of
considerable interest because of (1) the distinct pH modulation of
ATP responses at the homomeric P2X2 receptor (King, 1998), (2)
a growing belief that the P2X6 subunit might only contribute to
functional channels when other P2X subunits are present (Torres
et al., 1999), and (3) the recent identification of a pH-modulated
ATP receptor in those nuclei of rat brainstem where P2X2 and
P2X6 transcripts have been detected (Thomas et al., 1999;
Thomas and Spyer, 2000).
Thus, it was of interest to examine the contribution of the P2X6
subunit, when coexpressed with the pH-modulated P2X2 subunit,
to the operational profile of the resultant heteromeric P2X2/6
receptor expressed in defolliculated Xenopus oocytes. Differences
in the ways heteromeric P2X2/6 and homomeric P2X2 receptors
respond to nucleotidic agonists, suramin, pH, and Zn21 ions were
investigated in the oocyte expression system. The results establish
the P2X2/6 receptor as the fourth example of a heteropolymeric
ATP-gated ion channel that, in this case, possesses a pattern of
pH modulation of ATP responses distinct from other known
homomeric and heteromeric P2X receptors.
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MATERIALS AND METHODS
Oocyte preparation. Xenopus laevis frogs were killed by immersion in a
lethal dose in Tricaine (0.4% w/v, in tap water) and then decapitated, and
ovarian lobes were removed by blunt dissection. Xenopus oocytes (stages
V and VI) were defolliculated by a two-step process involving (1)
collagenase treatment (Type IA, 2 mg/ml in Ca 21-free Ringer’s solution,
for 2–3 hr) and (2) stripping away the follicle cell layer with fine forceps.
Defolliculated oocytes do not possess native P1 and P2 receptors (King
et al., 1996a,b) and are largely devoid of ecto-ATPases (Ziganshin et al.,
1995). Oocytes were stored in Barth’s solution (pH 7.5, at 4°C) contain-
ing (in mM): NaCl 110, KCl 1, NaHCO3 2.4, Tris HCl 7.5, Ca(NO3)2
0.33, CaCl2 0.41, MgSO4 0.82, supplemented with gentamycin sulfate, 50
mg/ l. Cells were injected cytosolically with cRNA for rP2X2 (40 nl, 0.002
mg/ml) or rP2X6 (40 nl, 1 mg/ml) or both rP2X2 and rP2X6 (40 nl of each)
and incubated for 48 hr at 18°C in Barth’s solution. Thereafter, injected
oocytes were kept at 4°C for up to 12 d until they were used in electro-
physiological experiments.
Electrophysiology. Membrane currents were recorded from cRNA-
injected oocytes using a twin-electrode voltage-clamp amplifier (Axo-
clamp 2A). The holding potential (Vh) was 250 mV, unless stated
otherwise. The voltage-recording and current-recording microelectrodes
(1–5 MV tip resistance) were filled with 3.0 M KCl. Oocytes were placed
in an electrophysiological chamber (volume, 0.5 ml) and superfused with
Ringer’s solution (5 ml/min, at 18°C) containing (in mM): NaCl 110, KCl
2.5, HEPES 5, CaCl2 1.8, adjusted to pH 7.5. Extracellular pH (pHe) was
adjusted with HCl (1.0N) or NaOH (1.0N) to reach the desired level.
Electrophysiological data were stored on magnetic tape using a DAT
recorder (Sony 1000ES) and displayed using a pen recorder (Gould
2200S).
Drug solutions. ATP and other nucleotides were prepared in Ringer’s
solution, and the pH of stock solutions was readjusted to the desired
level. Agonists were superfused, at the concentrations given in the text,
by a gravity-feed continuous flow system allowing the rapid addition and
washout of drugs. ATP was added for 120 sec or until the current reached
a peak, then washed off with Ringer’s solution for a period of 5 min.
Where used, antagonists were applied for 5 min before and during the
application of agonists.
Agonist responses were normalized to the maximum inward current
(Imax) evoked by ATP at pH 7.5, including agonist responses recorded at
lower pH levels. At pH 7.5, maximum responses were evoked by 300–
1000 mM ATP. The agonist concentration required to evoke 50% of the
maximum response (EC50) was taken from Hill plots, using the transform
log (I/Imax 2 I ), where I is the peak current evoked by each concentration
of ATP.
The potentiating effects of extracellular Zn 21 ions on agonist activity
were investigated in two ways. Zn 21 ions were either applied simulta-
neously with ATP or added to the Ringer’s solution for 5 min before
ATP was applied (with Zn 21 present).
Statistics and graphs. Data are presented as mean 6 SEM of four to
seven sets of data from different oocyte batches. Concentration–response
curves and inhibition curves were fitted by nonlinear regression analysis
using Prism v2.0 (GraphPad). Significant differences were determined by
unpaired Student’s t test or one-way ANOVA followed by Dunnett’s post
hoc test, again using Prism v2.0 (GraphPad).
Drugs and reagents. All common salts and reagents were AnalaR grade
(Aldrich Chemicals, Poole, UK). ATP and ATPaS were purchased from
Boehringer (Mannheim, Germany). 2-Methylthio ATP (2-MeSATP) was
obtained from RBI (Natick, MA), and other nucleotides [ATPgS, ADP,
AMP, adenosine, UTP, UDP, UMP, uridine, CTP, GTP, ITP, diade-
nosine polyphosphates (ApnA; n 5 2–6), a,b-meATP, b,g-meATP, and
29- and 39-O-(4-benzoyl-benzoyl)ATP (BzATP)] came from Sigma
(Poole, UK). Suramin was a gift from Bayer (Newbury, UK).
RESULTS
ATP responses of P2X receptors
In initial experiments, the functionality of homomeric rP2X2 and
rP2X6 receptors expressed in Xenopus oocytes was tested against
a near-saturating concentration of ATP (100 mM), according to
available pharmacological data on homomeric P2X receptors
(King, 1998). At a holding potential of 250 mV, ATP-activated
rP2X2 receptors produced fast-activating and slowly inactivating
inward currents (1993 6 147 nA; n 5 6) (Fig. 1A,C). rP2X6
receptors failed to respond to ATP at a holding potential 250
mV, but where increased to 290 mV, the agonist did evoke
low-amplitude slowly activating inward currents (4.57 6 1.31 nA,
n 5 7) (Fig. 1A,C). Control (water-injected) oocytes failed to
respond to ATP, at either 250 or 290 mV.
In further experiments, coexpression of rP2X2 and rP2X6 sub-
units resulted in fast-activating and slowly inactivating inward
currents (1516 6 286 nA, n 5 6) (Fig. 1B,C), which were broadly
similar in their time course to the ATP responses produced by
homomeric rP2X2 receptors. However, ATP-activated hetero-
meric rP2X2/6 receptors uniquely showed biphasic (transient and
sustained) components to the evoked inward currents (Fig. 1B,
closed arrow). Such biphasic responses were seen in all cRNA-
injected oocytes tested (n 5 175), although the amplitude of each
component of biphasic currents was variable from response to
response. Furthermore, evoked responses would change in an
unpredictable manner from biphasic to monophasic currents (and
back again) over several successive ATP applications. However,
the reproducibility of biphasic inward currents by rP2X2/6 recep-
Figure 1. Expression of homomeric and heteromeric P2X receptors. A,
Whole-cell inward currents by homomeric rP2X2 and rP2X6 receptors
activated by a near-saturating ATP concentration (100 mM, for 60 sec), at
the given holding potentials (Vh ). B, Whole-cell inward currents by
ATP-activated heteromeric rP2X2/6 receptors. ATP responses were often
biphasic, showing a transient component ( filled arrow) followed by a
sustained current. The deactivation of inward current occasionally
showed two phases of current decay (open arrow). C, Averaged whole-cell
inward currents by homomeric rP2X2 , rP2X6 , and heteromeric rP2X2/6
receptors activated by ATP (100 mM). The y-axis of the histogram has
been truncated to help reveal the small responses by rP2X6 receptors.
Data are expressed as mean 6 SEM for six to seven cells per
determination.
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tors was enhanced when pHe was lowered or Zn
21 ions were
present in the bathing solution (see Fig. 5). Deactivation of
rP2X2/6 receptors frequently comprised two phases of current
decay (Fig. 1B, open arrow). Neither biphasic inward currents nor
biphasic current decays were seen at rP2X2 receptors.
The concentration–response (C–R) relationship was studied
for ATP responses at rP2X2 and rP2X2/6 receptors, at pH 7.5 (Fig.
2A). ATP was more potent (approximately twofold) at rP2X2
receptors (EC50, 18 6 2.1 mM; nH 5 2.0 6 0.2) than rP2X2/6
receptors (EC50, 32 6 1.6 mM; nH 5 1.7 6 0.2) (p , 0.05, unpaired
t test). Since the potency of agonists at rP2X2 receptors is strongly
affected by pHe, the above differences in ATP activity could
potentially be attributed to incorrect pHe measurements. How-
ever, rP2X2 and rP2X2/6 receptors responded in different ways to
changes in pHe (Fig. 2B). The amplitude of ATP responses at
rP2X2 receptors increased over the range of pH 8.0 to 6.3 and was
maintained at lower pHe levels (up to pH 5.0). ATP responses at
rP2X2/6 receptors initially increased in size over the range of pH
8.0 to 6.3, then decreased in amplitude as pHe levels were lowered
further. The pKa value for the potentiating phase of the H
1 effect
was 7.04 6 0.05 (n 5 4) at P2X2/6 receptors, a value not signifi-
cantly different from that of P2X2 receptors (7.05 6 0.05; n 5 4).
However, the slopes of the curves describing the potentiating H1
effect were significantly different (P2X2/6, 1.83 6 0.31; P2X2,
3.04 6 0.22; p , 0.05).
The C–R relationship for ATP was reexamined at different pHe
levels for rP2X2/6 receptors. ATP potency was increased fourfold
at pH 6.5 and 15-fold at pH 5.5 (Table 1; see EC50 values). The
maximum response to ATP was unchanged at pH 6.5, but agonist
efficacy was significantly reduced (by 76 6 3%) at pH 5.5 (Fig.
2C). At rP2X2 receptors, acidification of the bathing solution
shifted the ATP C–R curve to the left without a reduction in the
maximum (Fig. 2D). ATP potency was increased 12-fold at pH
6.5 and 30-fold at pH 5.5 at rP2X2 receptors (Table 1; see EC50
values). The effects of lowering pHe were reversed on restoration
to pH 7.5 for both rP2X2 and rP2X2/6 receptors.
Agonist activity at P2X receptors
ATP, ATPaS, ATPgS, and 2-meSATP are known to be full
agonists at rP2X2 receptors (King et al., 1997), and consequently
their ability to activate rP2X2/6 receptors was investigated. Each
nucleotide (30 mM) elicited large, slowly inactivating inward cur-
rents at rP2X2/6 receptors, with an apparent potency order of
(estimated EC50 value) ATP (29.9 mM) 5 ATPgS (30.8 mM) .
2-MeSATP (34.8 mM) . ATPaS (40.6 mM) (Fig. 3A,C). BzATP
was a weak agonist at rP2X2/6 receptors (EC50, 399 mM) (Fig.
3A,C). P2X2/6 receptors did not respond to ADP, AMP, adeno-
sine, UTP, UDP, UMP, uridine, CTP, GTP, ITP, a,b-meATP,
and b,g-meATP (each tested at 30 and 100 mM) (data not shown).
Of the diadenosine polyphosphates tested (ApnA, n 5 2–6),
Ap4A alone showed activity but proved to be a weak agonist
(EC50, .1 mM) (Fig. 3B,C). This weak activity contrasted with
results from rP2X2 receptors, at which Ap4A is a full agonist
(EC50, 15.2 mM) (Pintor et al., 1996).
Suramin blockade at P2X receptors
Suramin is an effective antagonist at rP2X2 receptors, at which its
potency is enhanced when pHe levels are lowered (King et al.,
1997). Similar results were obtained for P2X2/6 receptors, with
suramin reducing ATP responses in a concentration-dependent
Table 1. Effect of extracellular pH on ATP potency
pHe rP2X2 receptor rP2X2/6 receptor
pH 7.5 16.2 6 1.4 32.0 6 1.6*
(1.8 6 0.2) (1.7 6 0.2)
pH 6.5 1.3 6 0.2 7.5 6 1.1*
(2.0 6 0.2) (1.5 6 0.3)
pH 5.5 0.55 6 0.04 2.2 6 0.7*
(2.1 6 0.3) (2.5 6 0.3)
EC50 values (mM) and Hill slopes (nH, in brackets) for ATP activation of rP2X2 and
rP2X2/6 receptors at the given extracellular pH (pHe) levels are shown. At each pHe
level tested, EC50 values were significantly different (*p , 0.05, by unpaired t test).
Data are expressed as mean 6 SEM (n 5 4).
Figure 2. ATP activity at homomeric and heteromeric P2X
receptors. A, C–R relationship for ATP-activated inward
currents at rP2X2 and rP2X2/6 receptors, at pH 7.5. B, The
relationship between the amplitude of ATP responses
(rP2X2 , 3 mM; rP2X2/6 , 10 mM; each producing 5% of the
maximum response) and the extracellular pH level (range,
pH 8.3–5.0) at homomeric and heteromeric P2X receptors.
C, The C–R curves for ATP activation of rP2X2/6 receptors
at the pHe levels indicated. ATP efficacy was markedly re-
duced at pH 5.5. D, The C–R curves for ATP activation of
rP2X2 receptors. ATP efficacy was not altered at pH 5.5.
Curves were fitted by the Hill equation in A–D (solid lines)
and by a single exponential function in B (dashed line). Data
given as mean 6 SEM for four to six cells per curve.
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manner and its potency enhanced with acidification of the bathing
solution (Fig. 4A,B). At pH 7.5, suramin was equipotent at rP2X2
and rP2X2/6 receptors (Table 2; see IC50 values). Differences in
blocking activity were only observed at lower pHe levels where, at
pH 6.5, the inhibition curve for suramin was biphasic for rP2X2/6
receptors and monophasic for rP2X2 receptors (Fig. 4C). Com-
parison of IC50 values at pH 6.5 revealed that activity indices for
each of the two phases of P2X2/6 receptor blockade was signifi-
cantly different ( p , 0.05, unpaired t test) compared with the IC50
value for rP2X2 receptors (Table 2). The blocking activity of
suramin at rP2X2 and rP2X2/6 receptors was reversed on washout,
at all pHe levels studied.
Actions of Zn21 ions at P2X receptors
Extracellular Zn21 is known to potentiate ATP responses at
P2X2 receptors (Wildman et al., 1998), although the degree of
potentiation depends on whether Zn21 is applied before, or
simultaneously with, the agonist. When applied 5 min before
ATP, Zn 21 ions (1–30 mM) progressively increased ATP re-
sponses at rP2X2/6 receptors, by 6- to 14-fold (averaging 9.82 6
2.29, n 5 6), whereas higher concentrations (30–300 mM) progres-
sively decreased and abolished ATP responses in a concentration-
dependent manner (Fig. 5A). The potentiating and inhibitory
effects were reversed on washout. Zn21 preincubation also af-
fected ATP responses by clearly increasing the incidence of
biphasic inward currents, a phenomenon also seen when pHe
levels were lowered (Fig. 5A,C). Where applied simultaneously
with ATP, Zn21 ions (1–300 mM) only caused a concentration-
dependent increase (8- to 25-fold; averaging 16.35 6 4.28, n 5 5)
in the amplitude of ATP responses at P2X2/6 receptors (Fig. 5B).
Without Zn21 preincubation, the above inhibitory Zn21 effect
was not seen, and the incidence of biphasic ATP responses was
inconsistent and infrequent for each oocyte tested. EC50 values
for the potentiating effects of Zn21 ions at rP2X2 and rP2X2/6
receptors were similar (Fig. 5, see legend).
DISCUSSION
In the present study, expression of homomeric rP2X6 receptors in
defolliculated Xenopus oocytes resulted in functional P2X recep-
tors that, even under heightened conditions for channel activa-
Figure 3. Nucleotide activation of rP2X2/6 receptors. In A, whole-cell
inward currents at the heteromeric rP2X2/6 receptor were evoked by ATP,
ATPgS, 2-MeSATP, ATPaS, and BzATP (30 mM), each of which is a
known agonist of rP2X2 receptors (King et al., 1997). In B, the rP2X2/6
receptor was activated weakly by Ap4A (30 and 300 mM), and the kinetics
of activation and deactivation were considerably slower than ATP re-
sponses. C, C–R relationship for agonist activation of rP2X2/6 receptors at
pH 7.5. Estimates of EC50 values (micromolar concentration) were made
using the “2 1 2 assay” method of Arunlakshana and Schild (1959): ATP,
29.9 6 1.9; ATPgS, 30.8 6 2.9; ATPaS, 40.6 6 8.0; 2-MeSATP, 34.8 6
5.1; BzATP, 399 6 66; Ap4A, .1000 (n 5 4–6). The dashed line shows the
position of the full C–R curve for ATP (redrawn from Fig. 2 A). Open and
filled arrows (in A and B) draw attention to biphasic components of
receptor activation and deactivation. Data are given as mean 6 SEM for
four to six cells per determination.
Figure 4. Suramin antagonism of rP2X2/6 receptors. Shown is antago-
nism of ATP responses (Vh 5 250 mV) at heteromeric rP2X2/6 receptors
by suramin at pH 7.5 (A) and pH 6.5 (B). Suramin was effective at
micromolar concentrations at pH 7.5, but the concentration range for
suramin blockade was extended at pH 6.5. C, Inhibition curves for
suramin blockade of ATP responses at rP2X2 and rP2X2/6 receptors at the
given pH levels. At pH 6.5, the inhibition curve for rP2X2/6 was fitted best
by a biphasic curve. IC50 values are given in Table 2. Open arrows draw
attention to biphasic current decays. Data are expressed as mean 6 SEM
for four to eight cells per curve. The biphasic curve for rP2X2/6 was
constructed from eight sets of data, using the results from the first two
log10 units of concentration (suramin, 0.001–0.01 mM) to represent the
first component of the inhibition curve.
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tion, only managed to produce low-amplitude responses. Such
weak ATP responses were attributed to the activation of just a
small number of functional rP2X6 receptors, because defollicu-
lated oocytes do not possess native P1 or P2 receptors to com-
plicate the analysis of agonist actions (King et al., 1996a,b).
Homomeric rP2X6 receptors have thus far been reported to
function well in human embryonic kidney (HEK) 293 cells (Buell
et al., 1996; Collo et al., 1996), to be silent in HEK 293 cells
(Torres et al., 1999), or not to function at all in Xenopus oocytes
(Soto et al., 1996; Leˆ et al., 1998). Our initial experiments thus
confirmed that there are difficulties associated with rP2X6 recep-
tor expression in Xenopus oocytes and, in all probability, in other
cell systems. It is possible that Xenopus oocytes and occasionally
HEK 293 cells fail to produce an essential protein necessary to
insert P2X6 subunits into the cell membrane. One plausible can-
didate for this protein is another P2X subunit, perhaps the P2X4
subunit, on the grounds that a P2X4-like cDNA (AF012903) has
been isolated from HEK 293 cells (direct submission GenBank by
Chang and Chang in 1996) and the P2X4 protein is present at low
levels in these cells (Worthington et al., 1999). The heteromeric
rP2X4/6 receptor is similar in its functional properties to the
operational profile of homomeric rP2X6 receptors (Leˆ et al.,
1998). Because ,5% of HEK 293 cells transfected with rP2X6
cDNA go on to assemble a functional P2X6 (or possibly P2X4/6-
like) receptor (Collo et al., 1996), the P2X4 subunit may not be
present in all HEK 293 cells.
Where coexpression of P2X2 and P2X6 subunits in Xenopus
oocytes was concerned, our experiments were based on a com-
parison of the operational profiles of wild-type rP2X2 receptors
and heteromeric rP2X2/6 receptors. The rP2X2 receptor has al-
ready been characterized in our laboratory in an extensive survey
of agonists, antagonists, and modulators at this ATP-gated ion
channel (King et al., 1996c, 1997; Pintor et al., 1996; Wildman et
al., 1997, 1998, 1999a,b,c). Torres and colleagues (1999) have
demonstrated that epitope-tagged rP2X2 and rP2X6 subunits will
coprecipitate when expressed in a heterologous expression sys-
tem. Thus, our present results confirm that functional hetero-
meric P2X2/6 receptors are indeed formed and inserted into the
membrane of Xenopus oocytes. Several key observations were
made on this new heteromeric P2X receptor, particularly (1) the
nature of the evoked inward currents, (2) the potency of agonists,
and (3) the effect of pH on ATP responses and suramin blockade.
ATP-evoked inward currents at heteromeric rP2X2/6 receptors
were sometimes biphasic in nature, involving transient and sus-
tained components that varied in amplitude from response to
response in the same cell. However, the incidence and reproduc-
ibility of biphasic responses in each oocyte varied in an unpre-
dictable manner. The incidence of biphasic currents was greater
and reproducibility more consistent when extracellular Zn21 was
present (Fig. 5A) or extracellular pH was lowered (Fig. 5C).
Biphasic currents have already been reported at homomeric
Figure 5. Modulation of ATP responses by Zn 21 and H 1 at rP2X2/6
receptors. A, Concentration-dependent potentiation and inhibition of
agonist-evoked inward currents by extracellular Zn 21 (1–100 mM) given 5
min before and during ATP application at rP2X2/6 receptors, at pH 7.5.
EC50 values (micromolar concentration) for Zn
21 potentiation of ATP
responses was rP2X2/6 , 6.8 6 1.0 versus rP2X2 , 6.9 6 1.1 (n 5 4). B,
Concentration-dependent potentiation of ATP-evoked inward currents by
extracellular Zn 21 (1–100 mM) applied simultaneously with the agonist.
Under these circumstances, biphasic currents were rarely seen, and the
inhibitory action of Zn 21 was lost. EC50 values (micromolar concentra-
tion) for Zn 21 potentiation of ATP responses were rP2X2/6 , 8.2 6 0.5
versus rP2X2 , 11.7 6 2.8 (n 5 6). C, Concentration-dependent potentia-
tion and inhibition of ATP-evoked inward currents by extracellular H 1
ions (pH 7.0–5.5) at rP2X2/6 receptors. pKa values (2log10[H
1] causing
50% potentiation) were rP2X2/6 , 7.04 6 0.05 versus rP2X2 , 7.05 6 0.05
(n 5 4). D, Paired biphasic inward currents evoked by ATP (100 mM, at
pH 7.5) at rP2X2/6 receptors with either Mg
21 or Ca 21 (1.8 mM) present
in the bathing solution. Substitution of Ca 21 with Mg 21 resulted in a
reduction of ATP potency [as shown for rP2X2 receptors (King et al.,
1997)] without significantly altering the appearance of biphasic currents.
Filled arrows draw attention to transient component of ATP-evoked
inward currents (A, C). Data are expressed as mean 6 SEM for four to six
cells per determination.
Table 2. Blockade by suramin of P2X receptors
pHe rP2X2 receptor rP2X2/6 receptor
pH 7.5 10.4 6 1.2 6.06 6 1.22
(20.83 6 0.12) (21.19 6 0.14)
pH 6.5 0.078 6 0.005 0.013 6 0.003 (I1)*
(21.19 6 0.08) (21.28 6 0.15)
1.61 6 0.28 (I2)*
(20.96 6 0.16)
IC50 values (mM) and Hill slopes (nH, in brackets) for suramin blockade of rP2X2 and
rP2X2/6 receptors at the given extracellular pH (pHe) levels are shown. The inhibi-
tion curve for suramin blockade of rP2X2/6 receptors was biphasic at pH 6.5, showing
high-affinity (I1) and low-affinity (I2) components of blockade of ATP responses
(Fig. 4C). The IC50 values of rP2X2 and rP2X2/6 receptors, at pH 6.5, were
significantly different (*p , 0.05, by unpaired t test). Data are expressed as mean 6
SEM (n 5 4 for rP2X2 at pH 7.5 and 6.5, and for rP2X2/6 at pH 7.5; n 5 8 for rP2X2/6
at pH 6.5).
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rP2X4 receptors, at which time-dependent changes in channel
permeability were observed and shifts in the reversal potential for
ATP-evoked currents noted (Khakh et al., 1999; Virginio et al.,
1999). The binary permeability properties of rP2X4 receptors
were seen only when extracellular Ca21 levels were lowered or
zero Ca21o conditions imposed (Khakh et al., 1999). Therefore,
we explored this possibility and found that biphasic responses at
heteromeric rP2X2/6 receptors were not enhanced when Ca
21
was replaced with equimolar Mg21 (Fig. 5D). Ca21-independent
binary permeability properties have been reported for homomeric
rP2X2 receptors, although the time- and concentration-
dependent changes in permeability do not result in biphasic
currents to ATP (Khakh et al., 1999; Virginio et al., 1999). Others
have reported, however, that rP2X2 receptor ion channels do not
show significant changes in unitary conductance or reversal po-
tential of whole-cell currents (Ding and Sachs, 1999b). This
inconsistency with the P2X2 receptor is reminiscent of the vari-
ability of agonist responses (monophasic and biphasic) at the
heteromeric P2X2/6 receptor. Currently, there is no satisfactory
explanation for biphasic ATP responses at heteromeric P2X2/6
receptors.
The potency of ATP was lower at heteromeric rP2X2/6 recep-
tors than homomeric rP2X2 receptors, regardless of the pH level
studied (Table 1). Although ATP potency was decreased overall,
the rank potency order for mononucleotidic agonists at the het-
eromeric receptor remained the same as at the rP2X2 receptor,
namely ATP 5 ATPgS . 2-MeSATP . ATPaS . BzATP. One
significant difference in agonist activity involved the dinucleotide
diadenosine tetraphosphate (Ap4A), which is a full and potent
agonist at rP2X2 receptors (Pintor et al., 1996; Wildman et al.,
1999a) and only a weak agonist at rP2X2/6 receptors. This differ-
ence in Ap4A activity is potentially important, because this dinu-
cleotide occurs naturally and is released in a Ca21-dependent
manner from central synaptosomes in rat brain (Pintor et al.,
1992). Therefore, Ap4A may subserve a transmitter role at ho-
momeric rP2X2 receptors but not at heteromeric rP2X2/6
receptors.
Extracellular pH is known to exert a profound effect on ATP
potency at homomeric rP2X2 receptors (King et al., 1996c, 1997;
Stoop et al., 1997; Wildman et al., 1997, 1998, 1999b,c; Stoop and
Quayle, 1998; Ding and Sachs, 1999a). A secondary inhibitory
effect is observed at very low pH levels (e.g., pH 4.2), at which
ATP responses rapidly desensitize, yet recover quickly, if pHe is
reversed to levels above pH 5.0, a phenomenon called “fade and
rebound” (Stoop and Quayle, 1998). The heteromeric rP2X2/6
receptor showed both the potentiating and inhibitory effects of
extracellular H1, and the pH ranges for these two separate effects
are compressed when compared with rP2X2 receptors. The inhib-
itory effect was caused by a reduction in agonist efficacy alone and
not a decrease in agonist potency, as evidenced by the lower
maximum for the ATP C–R curve at pH 5.5 (Fig. 2C). Because
some homomeric P2X receptors (rP2X1, rP2X3, rP2X4, and
rP2X7) also show a reduction in ATP activity when pHe is
lowered (Virginio et al., 1997; Wildman et al., 1999c), it is con-
ceivable that the observed H1 inhibitory effect at rP2X2/6 recep-
tors is caused as much by an action of H1 ions at the rP2X6
subunit as at the rP2X2 subunit.
The potency of suramin is progressively enhanced at rP2X2
receptors as pH is lowered, with blockade occurring at nanomolar
concentrations at pH 5.5 (King et al., 1997). The present results
now show that this is an attribute shared by heteromeric rP2X2/6
receptors, although subtle differences were observed at pH 6.5 for
suramin blockade of homomeric rP2X2 and heteromeric rP2X2/6
receptors. There appeared to be high-affinity (I1) and low-affinity
(I2) sites for suramin at rP2X2/6 receptors, and activity indices for
each component failed to match the corresponding IC50 value at
rP2X2 receptors. The precise cause of this unusual effect is as yet
unresolved. However, one possibility may involve differences in
the subunit composition of heteromeric P2X2/6 receptors, if sub-
populations of oligomeric assemblies containing different num-
bers of rP2X6 subunits were generated. Where shown to be
functional, the homomeric rP2X6 receptor (or even the hetero-
meric rP2X4/6 receptor) has been reported to be relatively insen-
sitive to suramin blockade (Collo et al., 1996; Leˆ et al., 1998). The
suramin insensitivity of the P2X6 subunit might help contribute to
biphasic inhibition curves seen at pH 6.5 with the heteromeric
P2X2/6 receptor.
The potentiating effect of extracellular Zn21 was not signifi-
cantly different at rP2X2 and rP2X2/6 receptors. However, one
subtle difference was noted when using high concentrations ($
100 mM) of this transition metal, which appeared to directly
activate the heteromeric rP2X2/6 receptors without the need for
exogenous ATP (data not shown). It is known that Xenopus
oocytes continuously extrude small amounts of intracellular ATP
via a mechanogated transport pathway (Nakamura and Strittmat-
ter, 1996), and consequently the potency of locally released ATP
may be sufficiently elevated by Zn21 ions to explain the apparent
Zn21-activated inward currents. The subsequent inhibition of
ATP responses by high concentrations of Zn21 ions may be
caused by a gradual desensitization of the receptor pool by locally
released ATP.
In conclusion, the heteromeric P2X2/6 receptor possesses a
significantly different operational profile from the wild-type P2X2
receptor. It is of interest to us that rP2X2 and rP2X6 transcripts
are found in rat brainstem (Collo et al., 1996; Comer et al., 1997)
in nuclei with demonstrable pH-dependent chemoreceptive in-
puts (Thomas et al., 1999). The pH modulation of the homomeric
P2X2 and heteromeric rP2X2/6 receptor forms an interesting basis
for examining the recently discovered involvement of ATP recep-
tors in the CO2-evoked (and pH-dependent) changes in central
respiratory drive in rat (Thomas et al., 1999; Thomas and Spyer,
2000). At this point in time, however, the present results establish
the P2X2/6 receptor as the fourth example of a heteropolymeric
ATP-gated ion channel, which in this case possesses a pattern of
pH modulation of ATP responses distinct from other known
homomeric and heteromeric P2X receptors.
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